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Relationship between Helicobacter pylori Virulence Genes and 
Clinical Outcomes in Saudi Patients 
Helicobacter pylori has been strongly associated with gastritis, gastric and duodenal ulcers, 
and it is a risk factor for gastric cancer. Two major virulence factors of H. pylori have been 
described: the cytotoxin-associated gene product (cagA) and the vacuolating toxin (vacA). 
Since considerable geographic diversity in the prevalence of H. pylori virulence factors has 
been reported, the aim of this work was to determine if there is a significant correlation 
between different H. pylori virulence genes (cagA and vacA) in 68 patients, from Saudi 
Arabia, and gastric clinical outcomes. H. pylor was recognized in cultures of gastric 
biopsies. vacA and cagA genes were detected by polymerase chain reaction (PCR). The 
cagA gene was obtained with 42 isolates (61.8%). The vacA s- and m- region genotypes 
were determined in all strains studied. Three genotypes were found: s1/m1 (28%), s1/m2 
(40%) and s2/m2 (26%). The s2/m1 genotype was not found in this study. The relation of 
the presence of cagA and the development of cases to gastritis and ulcer was statistically 
significant (P < 0.05). The study showed a significant correlation between the vacA s1/m2 
genotype and gastritis cases, and a significant correlation between vacA s1/m1 genotype 
and peptic ulcer cases. The results of this study might be used for the identification of 
high-risk patients who are infected by vacA s1/m1 genotype of H. pylori strains. In 
conclusion, H. pylori strains of vacA type s1 and the combination of s1/m1 were associated 
with peptic ulceration and the presence of cagA gene.
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INTRODUCTION
Helicobacter pylori (H. pylori) is a Gram-negative spiral bacteri-
um which colonizes the human stomach (1). Infections with H. 
pylori may induce chronic gastritis, peptic ulcer, gastric adeno-
carcinoma and gastric mucosa-associated lymphoid tissue lym-
phoma (MALT) (2). There is increasing evidence that the genetic 
variability of H. pylori may have a clinical importance (3). There 
are two bacterial virulence factors of H. pylori and their genes 
also serve as epidemiological markers. The vacA (vacuolating 
toxin) and the cagA (cytotoxin-associated gene) play a major 
role in determining the clinical outcome of Helicobacter infec-
tions (4). The vacA gene, encoding the vacuolating toxin, is con-
sidered an important virulence factor and it is present in all 
strains (5). Significant sequence polymorphisms within vacA 
can be found in the coding sequence for the signal peptide (re-
ferred to as the s-region) and in the middle of the gene, called 
the middle (m) region. There are two allelic types (m1 and m2) 
in the middle region while the signal region has either an s1 
(s1a, s1b, and s1c) or an s2 allele. The strains of the s1/m1 sub-
type typically produced higher levels the vacuolating cytotoxin 
than other genotypes, while s2/m2 strains do not secrete vacA 
(6). Toxins with different m- genotypes also display a differen-
tial specificity for intoxicating the target mammalian cells, with 
vacA m1 variants affecting wider range of target cells than those 
with m1 (7). 
  The product of the cagA gene is introduced into gastric epi-
thelial cells by the type IV secretion system, where it becomes 
phosphorylated and modulates various cellular processes and 
signal transduction pathways. The intracellular cagA activities 
associated with the development of gastric carcinoma include 
disruption of tight junctions and a the responses (8). The pres-
ence of the cagA gene is an important marker for the most viru-
lent strains associated with peptic ulcer, atrophic gastritis and 
adenocarcinoma (9). The cagA gene is a marker for the presence 
of the cag pathogenicity island and this gene with others on the 
island is associated with more severe clinical outcomes (10, 11). 
Atherton et al. (6) first reported a strong association between 
cagA and vacA signal sequence type s1/m1. 
  The patterns of H. pylori genotypes have been recently ana-
lyzed in several patient populations worldwide (6, 12-18). How-
ever, no such study has been carried out in Saudi Arabia. Here I 
report the results of such study and for the first time, investigate 
the prevalence of the cagA and vacA genotypes of H. pylori iso-Marie MAM  •  H. pylori  Virulence Genes and Clinical Outcomes 
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lates from gastric cultures and demonstrate their relationships 
with clinical outcomes. 
MATERIALS AND METHODS
Biopsy samples were obtained over a 6 months-period (January 
through June 2010) from selected patients referred for endos-
copy at different hospitals in Riyadh, Saudi Arabia. Sixty eight 
patients, who had H. pylori, were enrolled in this study. The 
mean age of the patients was 43 yr (range, 14-84) and 45% were 
female. Histologically, patients were classified into gastritis in 
37 cases (54.4%) and peptic ulceration in 31 cases (45.6%). One 
biopsy specimen taken from the antrum was used for the cul-
ture. All data of the subjects were collected from patient’s file.
H. pylori culture and DNA extraction
Antral biopsies were cut into small pieces, homogenized and 
were smeared on the surface of H. pylori selective agar (Oxoid, 
Basingstoke, Hants, UK) then incubated at 37°C in a BBL Gas-
Pak (Becton Dickinson Microbiology Systems, Cockeysville, MD, 
USA) containing a Campy-Pak Plus microaerophilic system gen-
erator (Becton Dickinson Microbiology Systems) for 7 days. The 
morphology of H. pylori clinical isolates colonies were smooth, 
translucent and small. Colonies that manifested the described 
characteristic morphologies were identified as H. pylori if they 
were Gram negative and shaped bacilli, and urease, catalase and 
oxidase positive. From the primary growth, seven or eight colo-
nies were pooled together, and genomic DNA was extracted with 
the QIAamp DNA mini kit (Qiagen, Hilden, Germany) accord-
ing to instructions of the manufacturer. The isolated DNA was 
eluted in 200 μL of 1 × TE buffer (10 mMTris-HCl, 1 mM EDTA 
[pH 8.0]) and stored at -20°C until use.
H. pylori genotyping for cagA and vacA
After DNA samples extraction, polymerase chain reactions (PCR) 
were carried out in a volume of 50 μL containing 1 μM of each 
primers, 1 μL of genomic DNA (approximately 200 ng), 1 mM of 
dNTPs mix, 2 mM of MgCl2, and 0.05 U/μL Taq DNA polymerase.
  PCR amplifications were carried out in GeneAmp PCR sys-
tem 9700 (Perkin Elmer, Norwalk, CT, USA). Table 1 summarized 
the primer sequences and the expected size of PCR products. 
The following cycle conditions were used: for cagA: 1 min at 94°C, 
1 min at 56°C, and 1 min at 72°C and for vacA: 35 cycles of 1 min 
at 94°C, 1 min at 53°C, and 1 min at 72°C. All runs included one 
negative and one positive DNA control. A 10 μL of amplified 
PCR products was then resolved by electrophoresis on 1.5% 
agarose gels run in acetate EDTA buffer and stained with ethid-
ium bromide. The PCR product was visualized under a short 
wave length ultraviolet light source (Fig. 1).
Data analysis 
Fisher’s exact test was used for analysis of data. A P value of 
< 0.05 was accepted as statistically significant.
Ethics statement 
Written informed consent was obtained from each participant 
before endoscopy.
RESULTS
Prevalence of cagA and vacA genotyping
The cagA gene was obtained with 42 isolates (61.8%) and 26 
(38.2%) were negative. The vacA s- and m- region genotype were 
determined in all strains studied. For the s-region, in strains 
where a single vacA s allele was found, the minority 18 (26%) 
contained the s2 allele. In 46 isolates contained s1 allele (68%), 
23 (34%) were subtype for each s1a and s1b. In the m-region, 2 
strains contained both m1 and m2 alleles. In the strains contain-
ing one single vacA m allele, the m1 allele was found in 19 iso-
lates (28%) and m2 in 45 ones (66%). Considering strains with 
Table 1. PCR primers for amplification of cagA and vacA sequences (19)
Region Primer Primer sequence (5´-3´)
PCR product 
size (bp)
cagA F1
B1
GATAACAGCCAAGCTTTTGAGG
CTGCAAAAGATTGTTTGGCAGA
349
vacA
   m1
 
   m2
 
   s1/s2
 
   s1b
 
   s1a
 
   s2
 
 
VA3-F
VA3-R
VA4-F
VA4-R
VA1-F
VA1-R
SS3-R
VA1-R
SS1-R
VA1-R
SS2-R
VA1-R
 
GGTCAAAATGCGGTCATGG
CCATTGGTACCTGTAGAAAC
GGAGCCCCAGGAAACATTG
CATAACTAGCGCCTTGCAC
ATGGAAATACAACAAACACAC
CTGCTTGAATGCGCCAAAC
AGCGCCATACCGCAAGAG
CTGCTTGAATGCGCCAAAC
GTCAGCATCACACCGCAAC
CTGCTTGAATGCGCCAAAC
GCTAACACGCCAAATGATGC
CTGCTTGAATGCGCCAAAC
 
290
 
352
 
259/286
 
187
 
190
 
199
 
	 1	 2	 3	 4	 5	 6	 7	 8
349	bp
149	bp
Fig. 1. PCR genotyping of vacA and cagA status from different cases. Primers de-
scribed in Table 1 were used for PCR reaction (Lanes- 1 = molecular weight marker; 
2 = cagA+; 3 = m1; 4 = m2; 5 = s1a; 6 = s1b; 7 = s2 and 8 = Negative control 
[without DNA]).Marie MAM  •  H. pylori  Virulence Genes and Clinical Outcomes 
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only one single vacA genotype, and taking vacA s- and m-region 
together, three genotypes were found: s1/m1 (28%), s1/m2 (40%) 
and s2/m2 (26%). The s2/m1 genotype was not found in this 
study (Table 2).
Relationship between H. pylori genotyping and clinical 
outcomes
While estimating relationship between potentially virulent H. 
pylori strains and clinical outcomes, significant differences (P <  
0.05) were found between isolates from gastritis and peptic ul-
cer cases (Table 3). The results showed a high percentage of cagA 
(70%) in peptic ulcer cases compared to gastritis cases (P < 0.05). 
The results showed a high percentage of m2/s1 with a distribu-
tion of 22 (59%) in gastritis cases (P < 0.05). In case of peptic ul-
cer, the highest rates were among m1/s1 with a frequency of 19 
(61%) (P < 0.05).
DISCUSSION
The geographic distribution of distinct H. pylori genotypes and 
the prevalence of virulent bacterial genotypes in several regions, 
particularly in Saudi Arabia, remain unknown. This study in-
cluded 68 selected patients, who were infected with H. pylori. 
In the present study, the distribution of cagA and vacA genes 
and their relationship to clinical outcomes were examined. The 
cagA gene was obtained with 42 isolates (61.8%). These results 
were in agreement with other studies conducted in Europe, Cen-
tral and South America, and East Asia where a higher prevalence 
(67% or more) of the cagA genotype was reported (20). For the 
vacA genotype, and when considering a single combined geno-
type, the results showed that the vacA s1 allele was predominant 
(68%) followed by the vacA s2 allele (26%). These are in contrary 
with a study in Kuwait reported that vacA s1 and s2 types were 
detected in approximately equal numbers in biopsies obtained 
from patients of Middle-Eastern origin, while North Africans 
were predominantly infected with the s2 type (21).
  The distribution of cagA was 54% in gastritis and 71% in pep-
tic ulcer cases. The relationship of the presence of cagA and the 
development of gastritis and peptic ulcer is statistically signifi-
cant (P < 0.05), which further substantiate the role of cagA as a 
marker for increased virulence of H. pylori. These findings are 
in agreement with several previous studies (22, 23). A large num-
ber of studies have shown increased risk of gastric cancer in peo-
ple with cagA positive H. pylori. However, other data have re-
vealed that the occurrence of gastric malignancy is independent 
of cagA status. A few studies have also implicated pivotal roles 
of other virulence factors (cagE, cagT, vacA, babA, and hrgA) in 
the etiology of gastric cancer. Several genotypes of H. pylori have 
been reported to possess higher predictive value for the devel-
opment of the severe form of the disease (24). Further study will 
be needed to determine the correlation between the H. pylori 
genotype and gastric cancer.
  In this study, the prevalence of the vacA genotypes s1/m1 was 
detected in 28%, s1/m2 in 40% and s2/m2 in 26%. No single case 
for vacA s2/m1 genotype was detected in this study. This find-
ing is in agreement with previous studies as this genotype was 
reported to be rare (12, 25). The most pathogenic vacA genotype 
(vacA s1/m1) was present in 61% of peptic ulceration cases, these 
are in agreement with previous studies in which association be-
tween this genotype and severe gastric outcomes were recog-
nized. These findings support the role of vacA s1/m1 genotype 
in severe clinical outcomes (13, 14, 26).
  In conclusion, the genotype may be used to identify patients 
who are at high risk for gastroduodenal disease. H. pylori strains 
with vacA type s1 and combination of s1/m1 are associated with 
peptic ulceration and the presence of cagA gene. This study sug-
gests that further investigation is necessary to better understand 
the genetic diversity of this pathogen in our region.
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